Decreased Tongue Strength is Related to Skeletal Muscle Mass in COPD Subjects
- Conditions
- Chronic Obstructive Pulmonary Disease
- Registration Number
- NCT04761380
- Lead Sponsor
- Kindai University
- Brief Summary
Background:
Dysphagia is frequently observed in subjects with chronic obstructive pulmonary disease (COPD). But tongue strength has not been investigated yet in COPD subjects. The investigators hypothesized that tongue strength is weaker in COPD subjects compared to normal subjects.
Methods:
This was a single-centre, observational, and cross-sectional study. Twenty-seven subjects with COPD and twenty-four age-matched control subjects were enrolled in this study. Isometric tongue strength was measured using a device fitted with a disposable oral balloon probe. The investigators also evaluated handgrip strength, gait speed, and appendicular skeletal muscle mass (ASM) to define participants as having sarcopenia. ASM, fat free mass index (FFMI), and skeletal muscle mass index (SMI) were measured by bioelectrical impedance analysis. Gait speed was measured using the 6-meter walking test. The eating assessment test-10 (EAT-10) was used to diagnose dysphagia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 51
- Clinical diagnosis of stable COPD.
- Age-matched control subjects who did not have any pulmonary disease.
- Participants with metallic implants.
- History of stroke disease.
- History of neuromuscular disease.
- Participants who did not have their front teeth.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method maximum tongue pressure 1 day To measure maximum tongue pressure (MTP), the balloon was positioned on the anterior palate with the lips closed. Subjects raised their tongue and compressed the balloon onto the palate with maximal voluntary muscular effort for approximately 7s. The measurement was taken three times with a 1-min interval. The maximum value was recorded as the MTP.
- Secondary Outcome Measures
Name Time Method fat free mass index (FFMI) 1 day FFMI (kg/m\^2) was calculated by fat free mass/height\^2(m\^2).
skeletal muscle mass 1 day Skeletal muscle mass was measured using the medical body composition analyzer. It is designed for measurements in the supine position, using four pairs of electrodes (eight electrodes in total), positioned on each hand and foot21. Supine measurements were taken after lying down for 10 minutes. Alcohol was prohibited for 24h prior to the impedance measurements.
height 1 day handgrip strength 1 day Handgrip strength was measured three times for the right hand using a grip strength dynamometer and mean values were used.
skeletal muscle mass (SMI) 1 day SMI (kg/m\^2) was calculated by skeletal muscle mass /height\^2(m\^2).
fat free mass 1 day Fat free mass was measured using the medical body composition analyzer. It is designed for measurements in the supine position, using four pairs of electrodes (eight electrodes in total), positioned on each hand and foot21. Supine measurements were taken after lying down for 10 minutes. Alcohol was prohibited for 24h prior to the impedance measurements.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Kindai University Faculty of Medicine
🇯🇵Ōsaka-sayama, Osaka, Japan
Kindai University Faculty of Medicine🇯🇵Ōsaka-sayama, Osaka, Japan